NEXGEL, INC. - 10-Q Filing

NexGel, Inc. reports Q3 financial results and discloses Celularity transaction details alongside stock reserve sufficiency concerns. (Items: 9.01 of Form 8-K in connection with the Celularity Transaction, and (iii) the sufficiency of the Company’s reserve of authorized and unissued shar)

SEC EDGAR ·

Tickers: $NXGL

Read the full article at SEC EDGAR

More Regulatory news